Zura Bio Inc
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense (NCT06993610) | Zura Bio Inc | 2025-05-16 |
| Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) (NCT06843239) | Zura Bio Inc | 2025-02-06 |
Track Zura Bio Inc automatically
Every clearance here is in the API, with alerts when new ones post.